Back to search
Acute Lung Inflammation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Lung Inflammation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Lung Inflammation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have long-term symptoms that affect the brain. These include he…
This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obta…
The proposed study is a prospective, observational study assessing the recovery of muscle and physical function in patients surviving critical illness (n =150)…
The goal of this clinical trial is to learn whether methylprednisolone improves outcomes in critically ill patients with a hyperinflammatory phenotype. It will…
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for…
This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation
Background: \- When bacteria enter the lungs, serious infections can occur. Researchers want to learn more about the process of inflammation in the lungs by st…